Bill Text: TX HB2250 | 2019-2020 | 86th Legislature | Engrossed

---

Bill Title: Relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Engrossed - Dead) 2019-05-13 - Referred to Health & Human Services [HB2250 Detail]

Download: Texas-2019-HB2250-Engrossed.html

---

86R11678 BEE-F
By: Lucio III, Thompson of Harris H.B. No. 2250

A BILL TO BE ENTITLED
AN ACT
relating to the prescribing and ordering of Schedule II controlled
substances by certain advanced practice registered nurses and
physician assistants.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Sections 157.0511(a) and (b), Occupations Code,
are amended to read as follows:
(a) A physician's authority to delegate the prescribing or
ordering of a drug or device under this subchapter is limited to:
(1) nonprescription drugs;
(2) dangerous drugs; and
(3) controlled substances to the extent provided by
Subsection [Subsections] (b) [and (b-1)].
(b) A [Except as provided by Subsection (b-1), a] physician
may delegate the prescribing or ordering of a controlled substance
only if:
(1) the prescription is for a controlled substance
listed in Schedule II, III, IV, or V as established by the
commissioner of state health services [the Department of State
Health Services] under Chapter 481, Health and Safety Code;
(2) the prescription, including any [a] refill of the
prescription, is for a period not to exceed 90 days;
(3) with regard to the refill of a prescription, the
refill is authorized after consultation with the delegating
physician and the consultation is noted in the patient's chart; and
(4) with regard to a prescription for a child less than
two years of age, the prescription is made after consultation with
the delegating physician and the consultation is noted in the
patient's chart.
SECTION 2. Section 157.0511(b-1), Occupations Code, is
repealed.
SECTION 3. This Act takes effect September 1, 2019.